Tue, Sep 24, 2013 11:00 AM
Voluntary public purchase offer
Voluntary public purchase offer in the attached document.

Egis Pharmaceuticals PLC (Egis) announces that it has received today a voluntary public
purchase offer (Offer) from Arts et Techniques du Progrès (Offeror), a wholly owned
subsidiary of Servier Group (Servier) to acquire all of the outstanding shares of Egis stock not
owned by the Offeror at a price of HUF 28,000 per share in cash. Currently, the Offeror owns
approximately 51% of the shares of Egis.


A meeting of the Board of Directors of Egis will be convened to discuss and vote on the
opinion concerning the Offer.


Egis hereby publishes the prospectus of the Offer and the related Operation Plan and
Business Report that were sent to it by the Offeror. Egis draws the attention of the
shareholders that the Offer has been submitted to the Hungarian Financial Supervisory
Authority but it has not been approved yet

Related file

WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox